OPEN APP
Home / News / India /  Omicron: India may see explosive growth in daily Covid cases within days, but for a short period

Omicron: India may see explosive growth in daily Covid cases within days, but for a short period

A BMC health worker is collecting swab sample for Covid test of a passenger at CST in Mumbai (Satish Bate/HT Photo)Premium
A BMC health worker is collecting swab sample for Covid test of a passenger at CST in Mumbai (Satish Bate/HT Photo)

  • It is likely that India will see a period of explosive growth in daily cases and that the intense growth phase will be relatively short, Paul Kattuman, professor at the Judge Business School at the University of Cambridge

Listen to this article

India may see a spurt in Covid-19 growth rate within days and head into an intense but short-lived virus wave as the highly-infectious omicron variant moves through the crowded nation of almost 1.4 billion.

“It is likely that India will see a period of explosive growth in daily cases and that the intense growth phase will be relatively short," Paul Kattuman, professor at the Judge Business School at the University of Cambridge which has developed a Covid-19 India tracker, wrote in an email. “New infections will begin to rise in a few days, possibly within this week," he said, adding that it was hard to predict how high the daily cases could go.

Kattuman and his team of researchers, developers of the India Covid tracker, are seeing a sharp rise in infection rates across India. The tracker spotlighted six states as a “significant concern" in a Dec. 24 note, with adjusted growth rate of new cases exceeding 5%. This had expanded to 11 Indian states by Dec. 26, according to the tracker, which corrects for “day of the week effects" and other variations.

India, which has confirmed 34.8 million infections and 480,290 deaths so far, is already gearing up to deal with another massive outbreak even though only 653 cases of the highly-mutated omicron have been identified so far. Last week, it allowed booster shots and included teenagers aged 15 to 18 in the inoculation program. Two more vaccines as well as Merck & Co.’s antiviral pill molnupiravir were approved by the local drug regulator Tuesday. 

These policy decisions underscore hard lessons India learned after a deadly delta-led virus wave in April and May that pushed infections to a record-beating 400,000-plus each day. It overwhelmed the country’s hospitals and crematoriums and left its citizens pleading for oxygen and other medical resources on social-media platforms.

The Cambridge India tracker had correctly called the peak of this devastating second wave in May and also forecast in August that India would see a slow burn in its Covid infections curve until the vaccination coverage was sufficiently high. India crossed 1 billion administered vaccine doses in October and new cases plunged in tandem with that milestone.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout